Waiting times for cancer referrals highest on record
93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks but this has fallen to just 75%
Read More
Author: John Pinching
Study into prophylaxis treatment meets key endpoints
Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A
Read More
SMC approval welcome news for breast cancer patients
Trodelvy is accepted for use in mTNBC patients who have already received two or more systemic therapies
Read More
Gene team supports therapies for previously untreatable brain regions
Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders
Read More
Cell door: EMA grants ATMP classification to CELTIC-19
Advanced Therapy Medicinal Product classification for Ixaka Ltd’s chemically encapsulated lentiviral vector
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
